about
3D MPRAGE improves classification of cortical lesions in multiple sclerosisPhysiological Dynamics in Demyelinating Diseases: Unraveling Complex Relationships through Computer Modeling.Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristicsThe blood-brain barrier in cortical multiple sclerosis lesionsTwo-photon laser scanning microscopy imaging of intact spinal cord and cerebral cortex reveals requirement for CXCR6 and neuroinflammation in immune cell infiltration of cortical injury sitesThalamus pathology in multiple sclerosis: from biology to clinical application.Imaging as an Outcome Measure in Multiple Sclerosis.Analysis of the mitochondrial proteome in multiple sclerosis cortex.White matter abnormalities: Insights into the pathophysiology of major affective disordersPrevalence of grey matter pathology in early multiple sclerosis assessed by magnetization transfer ratio imagingThe role of infections in the pathogenesis and course of multiple sclerosis.The neuropathological basis of clinical progression in multiple sclerosis.Shifting imaging targets in multiple sclerosis: from inflammation to neurodegeneration.Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE.The immunological basis for treatment of multiple sclerosis.Perturbed glucose metabolism: insights into multiple sclerosis pathogenesisSmall heat shock proteins are induced during multiple sclerosis lesion development in white but not grey matter.Immunopathogenesis of multiple sclerosis: concepts and controversies.Individual Assessment of Brain Tissue Changes in MS and the Effect of Focal Lesions on Short-Term Focal Atrophy Development in MS: A Voxel-Guided Morphometry Study.Neuronal Hemoglobin Expression and Its Relevance to Multiple Sclerosis Neuropathology.The extracellular matrix in multiple sclerosis pathology.Role of toll-like receptors in multiple sclerosis.The cuprizone model for demyelination.Loss of galectin-3 decreases the number of immune cells in the subventricular zone and restores proliferation in a viral model of multiple sclerosis.Brain extracellular matrix in neurodegeneration.In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI.Decreased NAA in gray matter is correlated with decreased availability of acetate in white matter in postmortem multiple sclerosis cortex.Comparison of double inversion recovery and conventional magnetic resonance brain imaging in patients with multiple sclerosis and relations with disease disability.An animal model of cortical and callosal pathology in multiple sclerosis.Application of quantitative proteomics technologies to the biomarker discovery pipeline for multiple sclerosis.Molecular biomarkers of neurodegeneration.Lesion Expansion in Experimental Demyelination Animal Models and Multiple Sclerosis Lesions.The neuronal metabolite NAA regulates histone H3 methylation in oligodendrocytes and myelin lipid composition.A B Cell-Driven Autoimmune Pathway Leading to Pathological Hallmarks of Progressive Multiple Sclerosis in the Marmoset Experimental Autoimmune Encephalomyelitis Model.The influence of HLA-DRB1*15 on motor cortical pathology in multiple sclerosis.Evolution of cortical and thalamus atrophy and disability progression in early relapsing-remitting MS during 5 years.Clinically benign multiple sclerosis despite large T2 lesion load: can we explain this paradox?Cerebral blood flow modulation insufficiency in brain networks in multiple sclerosis: A hypercapnia MRI study.Thalamus Degeneration and Inflammation in Two Distinct Multiple Sclerosis Animal Models.Blood-brain barrier alterations in the cerebral cortex in experimental autoimmune encephalomyelitis.
P2860
Q22065339-8EC664CB-F91F-4FED-8623-D6756DBBE1CBQ26786977-A0832283-CCB0-4794-9E9F-5063DB0DCECAQ26998412-413EFB39-5360-455A-9FA4-69076FFDD974Q28296839-795E85A3-0688-4E0B-8060-3A634B4AE504Q30492842-A1B53AE0-F639-4CB4-9F25-4AF6104149FBQ30871067-B2EC9899-CA56-43A6-9473-AFCEA43FB18AQ31134617-66DFF82F-542C-4B4A-9E4F-CF94EE37087BQ33812214-21BAE8DF-CEAB-4D2D-93A5-51C168BF5FF8Q33812847-33AAE34C-68CD-4D6E-B56B-105BA3A547ABQ34031708-FAB504D7-8018-460A-97F3-4AEDD0E0FD6DQ34075874-3D5F8CF4-2AF7-406D-BF96-487848D0E07EQ34188436-26247EFB-8BAB-47D1-86D2-9B97BE670729Q34303664-C28F6BD6-0D4D-473C-A578-32B4BBB937FAQ34552395-609DFFF9-FA98-408F-BF30-8A0082D97D29Q34582895-DCE57686-76EF-4AFF-99C7-6A3A59B1652DQ34595607-CD34579D-C330-493D-A707-01A3A6B1F26AQ36398055-9B46E32A-60AC-4FE9-86C5-D7C58719E40AQ36785951-E5535BCD-A46B-452A-803B-CF363429F8FEQ36847008-75FDE3A6-B1C3-47B1-ACC4-33D6A8FD75F4Q36854014-2E7A976D-623F-4CF1-981A-5C761C1A3FA5Q36940050-C00E9E70-5152-4323-927D-0E34E5BEF417Q37021687-1332EF58-249D-478D-B099-0B4B438253A2Q37148502-BDB63F9E-B03C-4ACC-8D32-CAFBD8079493Q37183047-B4B3FA02-C3CB-4472-9184-824FB5D01C42Q37228777-2E7585ED-7D32-4CC1-B56F-0BF6957C2E4CQ37368376-59504B4A-4B57-4B48-9024-B4102711AB44Q37432950-DB319E45-B099-442E-88AC-D42886B03E57Q37582717-260067F4-DAEC-4277-AD1E-C5266BE4197DQ37584143-61A74B5E-749A-475B-9CA9-849EB0306559Q38056688-0FE120ED-BD91-4971-AC11-7EDDEC0D67C0Q38154930-EE00704E-6AB0-4D42-9C5D-88A32AC5133DQ38964699-F9D87267-0237-4663-973B-98D85A46C54CQ39317856-FA1BCF57-8630-408B-9F17-D7C7CA505215Q39458392-E1CE5804-F3B9-416C-A83C-F148AF665DEAQ43426688-8E10ABC6-22D1-4293-B37D-4A1C4826002BQ46466612-1E2006C9-3062-4F64-AC57-C9DFD28424A2Q46912034-D185507C-5ADD-4327-941E-13F5CE1E6C65Q46943424-7358B1C3-8C96-450F-9444-1526686B30D6Q48127262-4BE887A2-6CE0-4FF0-ACEB-510963581015Q48366273-BCEDD485-7A6A-4AC6-9B4F-A8F114335767
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Grey matter pathology in multiple sclerosis.
@ast
Grey matter pathology in multiple sclerosis.
@en
type
label
Grey matter pathology in multiple sclerosis.
@ast
Grey matter pathology in multiple sclerosis.
@en
prefLabel
Grey matter pathology in multiple sclerosis.
@ast
Grey matter pathology in multiple sclerosis.
@en
P2093
P2860
P921
P1476
Grey matter pathology in multiple sclerosis.
@en
P2093
P2860
P356
10.1111/J.1600-0404.2006.00615.X
P577
2006-01-01T00:00:00Z